Trial Profile
A Multicenter, Randomized, Double-Masked, Active-Controlled Study to Evaluate the Safety and Efficacy of LME636 in Patients With Acute Anterior Uveitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2022
Price :
$35
*
At a glance
- Drugs Licaminlimab (Primary) ; Dexamethasone
- Indications Anterior uveitis
- Focus Proof of concept; Therapeutic Use
- Sponsors Alcon
- 22 Nov 2022 Primary endpoint (Number of Responders at Day 15) has been met as per Oculis media release
- 22 Nov 2022 According to an Oculis media release, data from this study published in Translational Vision Science & Technology (TVST), an ARVO journal
- 22 Nov 2022 Results published in the Oculis Media Release